 | • レポートコード：GIR-107A12609 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、プレミックスインスリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。プレミックスインスリンの種類別市場規模（プレミックスヒトインスリン、プレミックスインスリンアナログ）、用途別市場規模（家庭用、医療機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・プレミックスインスリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novo Nordisk、Eli Lilly、Teva、Pfizer、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プレミックスヒトインスリン、プレミックスインスリンアナログ ・用途別分析2016年-2026年：家庭用、医療機関、その他 ・プレミックスインスリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・プレミックスインスリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・プレミックスインスリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・プレミックスインスリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・プレミックスインスリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Premix Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Premix Insulin size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Premix Insulin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Premix Insulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Premixed Human Insulin
Premixed Insulin Analogues
Market segment by Application, can be divided into
Home Use
Medical Institutions
Others
Market segment by players, this report covers
Novo Nordisk
Eli Lilly
Teva
Pfizer
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Premix Insulin
1.2 Classification of Premix Insulin by Type
1.2.1 Overview: Global Premix Insulin Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Premix Insulin Revenue Market Share by Type in 2020
1.2.3 Premixed Human Insulin
1.2.4 Premixed Insulin Analogues
1.3 Global Premix Insulin Market by Application
1.3.1 Overview: Global Premix Insulin Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Global Premix Insulin Market Size & Forecast
1.5 Global Premix Insulin Market Size and Forecast by Region
1.5.1 Global Premix Insulin Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Premix Insulin Market Size by Region, (2016-2021)
1.5.3 North America Premix Insulin Market Size and Prospect (2016-2026)
1.5.4 Europe Premix Insulin Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Premix Insulin Market Size and Prospect (2016-2026)
1.5.6 South America Premix Insulin Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Premix Insulin Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Premix Insulin Market Drivers
1.6.2 Premix Insulin Market Restraints
1.6.3 Premix Insulin Trends Analysis
2 Company Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Premix Insulin Product and Solutions
2.1.4 Novo Nordisk Premix Insulin Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novo Nordisk Recent Developments and Future Plans
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Premix Insulin Product and Solutions
2.2.4 Eli Lilly Premix Insulin Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Eli Lilly Recent Developments and Future Plans
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Premix Insulin Product and Solutions
2.3.4 Teva Premix Insulin Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Teva Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Premix Insulin Product and Solutions
2.4.4 Pfizer Premix Insulin Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Premix Insulin Product and Solutions
2.5.4 Sanofi Premix Insulin Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Premix Insulin Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Premix Insulin Players Market Share
3.2.2 Top 10 Premix Insulin Players Market Share
3.2.3 Market Competition Trend
3.3 Premix Insulin Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Premix Insulin Revenue and Market Share by Type (2016-2021)
4.2 Global Premix Insulin Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Premix Insulin Revenue Market Share by Application (2016-2021)
5.2 Premix Insulin Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Premix Insulin Revenue by Type (2016-2026)
6.2 North America Premix Insulin Revenue by Application (2016-2026)
6.3 North America Premix Insulin Market Size by Country
6.3.1 North America Premix Insulin Revenue by Country (2016-2026)
6.3.2 United States Premix Insulin Market Size and Forecast (2016-2026)
6.3.3 Canada Premix Insulin Market Size and Forecast (2016-2026)
6.3.4 Mexico Premix Insulin Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Premix Insulin Revenue by Type (2016-2026)
7.2 Europe Premix Insulin Revenue by Application (2016-2026)
7.3 Europe Premix Insulin Market Size by Country
7.3.1 Europe Premix Insulin Revenue by Country (2016-2026)
7.3.2 Germany Premix Insulin Market Size and Forecast (2016-2026)
7.3.3 France Premix Insulin Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Premix Insulin Market Size and Forecast (2016-2026)
7.3.5 Russia Premix Insulin Market Size and Forecast (2016-2026)
7.3.6 Italy Premix Insulin Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Premix Insulin Revenue by Type (2016-2026)
8.2 Asia-Pacific Premix Insulin Revenue by Application (2016-2026)
8.3 Asia-Pacific Premix Insulin Market Size by Region
8.3.1 Asia-Pacific Premix Insulin Revenue by Region (2016-2026)
8.3.2 China Premix Insulin Market Size and Forecast (2016-2026)
8.3.3 Japan Premix Insulin Market Size and Forecast (2016-2026)
8.3.4 South Korea Premix Insulin Market Size and Forecast (2016-2026)
8.3.5 India Premix Insulin Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Premix Insulin Market Size and Forecast (2016-2026)
8.3.7 Australia Premix Insulin Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Premix Insulin Revenue by Type (2016-2026)
9.2 South America Premix Insulin Revenue by Application (2016-2026)
9.3 South America Premix Insulin Market Size by Country
9.3.1 South America Premix Insulin Revenue by Country (2016-2026)
9.3.2 Brazil Premix Insulin Market Size and Forecast (2016-2026)
9.3.3 Argentina Premix Insulin Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Premix Insulin Revenue by Type (2016-2026)
10.2 Middle East & Africa Premix Insulin Revenue by Application (2016-2026)
10.3 Middle East & Africa Premix Insulin Market Size by Country
10.3.1 Middle East & Africa Premix Insulin Revenue by Country (2016-2026)
10.3.2 Turkey Premix Insulin Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Premix Insulin Market Size and Forecast (2016-2026)
10.3.4 UAE Premix Insulin Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Premix Insulin Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Premix Insulin Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Premix Insulin Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Premix Insulin Revenue (USD Million) by Region (2016-2021)
Table 5. Global Premix Insulin Revenue Market Share by Region (2021-2026)
Table 6. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 7. Novo Nordisk Major Business
Table 8. Novo Nordisk Premix Insulin Product and Solutions
Table 9. Novo Nordisk Premix Insulin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 11. Eli Lilly Major Business
Table 12. Eli Lilly Premix Insulin Product and Solutions
Table 13. Eli Lilly Premix Insulin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Teva Corporate Information, Head Office, and Major Competitors
Table 15. Teva Major Business
Table 16. Teva Premix Insulin Product and Solutions
Table 17. Teva Premix Insulin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Premix Insulin Product and Solutions
Table 21. Pfizer Premix Insulin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanofi Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi Major Business
Table 24. Sanofi Premix Insulin Product and Solutions
Table 25. Sanofi Premix Insulin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Premix Insulin Revenue (USD Million) by Players (2019-2021)
Table 27. Global Premix Insulin Revenue Share by Players (2019-2021)
Table 28. Breakdown of Premix Insulin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Premix Insulin Players Head Office, Products and Services Provided
Table 30. Premix Insulin Mergers & Acquisitions in the Past Five Years
Table 31. Premix Insulin New Entrants and Expansion Plans
Table 32. Global Premix Insulin Revenue (USD Million) by Type (2016-2021)
Table 33. Global Premix Insulin Revenue Share by Type (2016-2021)
Table 34. Global Premix Insulin Revenue Forecast by Type (2021-2026)
Table 35. Global Premix Insulin Revenue by Application (2016-2021)
Table 36. Global Premix Insulin Revenue Forecast by Application (2021-2026)
Table 37. North America Premix Insulin Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Premix Insulin Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Premix Insulin Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Premix Insulin Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Premix Insulin Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Premix Insulin Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Premix Insulin Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Premix Insulin Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Premix Insulin Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Premix Insulin Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Premix Insulin Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Premix Insulin Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Premix Insulin Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Premix Insulin Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Premix Insulin Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Premix Insulin Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Premix Insulin Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Premix Insulin Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Premix Insulin Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Premix Insulin Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Premix Insulin Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Premix Insulin Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Premix Insulin Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Premix Insulin Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Premix Insulin Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Premix Insulin Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Premix Insulin Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Premix Insulin Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Premix Insulin Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Premix Insulin Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Premix Insulin Picture
Figure 2. Global Premix Insulin Revenue Market Share by Type in 2020
Figure 3. Premixed Human Insulin
Figure 4. Premixed Insulin Analogues
Figure 5. Premix Insulin Revenue Market Share by Application in 2020
Figure 6. Home Use Picture
Figure 7. Medical Institutions Picture
Figure 8. Others Picture
Figure 9. Global Premix Insulin Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Premix Insulin Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Premix Insulin Revenue Market Share by Region (2016-2026)
Figure 12. Global Premix Insulin Revenue Market Share by Region in 2020
Figure 13. North America Premix Insulin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Premix Insulin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Premix Insulin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Premix Insulin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Premix Insulin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Premix Insulin Market Drivers
Figure 19. Premix Insulin Market Restraints
Figure 20. Premix Insulin Market Trends
Figure 21. Novo Nordisk Recent Developments and Future Plans
Figure 22. Eli Lilly Recent Developments and Future Plans
Figure 23. Teva Recent Developments and Future Plans
Figure 24. Pfizer Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. Global Premix Insulin Revenue Share by Players in 2020
Figure 27. Premix Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Premix Insulin Revenue Market Share in 2020
Figure 29. Global Top 10 Players Premix Insulin Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Premix Insulin Revenue Share by Type in 2020
Figure 32. Global Premix Insulin Market Share Forecast by Type (2021-2026)
Figure 33. Global Premix Insulin Revenue Share by Application in 2020
Figure 34. Global Premix Insulin Market Share Forecast by Application (2021-2026)
Figure 35. North America Premix Insulin Sales Market Share by Type (2016-2026)
Figure 36. North America Premix Insulin Sales Market Share by Application (2016-2026)
Figure 37. North America Premix Insulin Revenue Market Share by Country (2016-2026)
Figure 38. United States Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Premix Insulin Sales Market Share by Type (2016-2026)
Figure 42. Europe Premix Insulin Sales Market Share by Application (2016-2026)
Figure 43. Europe Premix Insulin Revenue Market Share by Country (2016-2026)
Figure 44. Germany Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Premix Insulin Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Premix Insulin Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Premix Insulin Revenue Market Share by Region (2016-2026)
Figure 52. China Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Premix Insulin Sales Market Share by Type (2016-2026)
Figure 59. South America Premix Insulin Sales Market Share by Application (2016-2026)
Figure 60. South America Premix Insulin Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Premix Insulin Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Premix Insulin Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Premix Insulin Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Premix Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source
世界の遺伝子組換え型ヒトインスリン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界の人間インスリン治療薬＆デリバリーデバイス市場 2021：企業別、地域別、種類・用途別 The Human Insulin Drugs And Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の人間インスリンデリバリーシステム市場 2021：企業別、地域別、種類・用途別 The Human Insulin Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の自動インスリン送達システム市場 2021：企業別、地域別、種類・用途別 The Automatic Insulin Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のインスリンペンインジェクター市場 2021：企業別、地域別、種類・用途別 The Insulin Pen Injectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…